Aegon Ltd. (AEG) Q2 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call showed mixed results: strong performance in asset management and protection solutions, but a decrease in the US operating result. The solvency ratio decreased, yet a share buyback is positive. The Q&A highlighted uncertainties in management actions and remittances, with no major concerns. Overall, the financials and guidance are balanced, leading to a neutral sentiment.
Key Financial Performance
IFRS Operating Result EUR750 million, a decrease of 8% year-over-year due to unfavorable mortality claims experience in the US.
Operating Capital Generation (OCG) EUR588 million, a decrease of 5% year-over-year, impacted by unfavorable claims experience and higher new business strain.
Free Cash Flow EUR373 million, reflecting planned remittances from all units and included the final 2023 dividend payment from ASR.
Cash Capital at Holding EUR2.1 billion, a decrease due to returning capital to stockholders, including the completion of a EUR1.5 billion share buyback program.
Shareholder's Equity per Share EUR4.02, a decrease of EUR0.25 compared to the end of 2023, primarily due to capital returns to shareholders.
Total Comprehensive Income EUR84 million, with gains in OCI related to asset disposals and revaluations due to currency movements offsetting negative net results.
New Life Sales (International Segment) Decreased by 20% year-over-year, with weaker sales in China and Spain offsetting a 9% increase in Brazil.
Net Deposits (Savings & Investments Segment) $1.2 billion in the first half of 2024, supported by a large pooled plan sale.
Net Deposits (UK Workplace Platform) GBP1.7 billion, driven by inflows on new schemes and higher net deposits on existing schemes.
Operating Result from Aegon Asset Management Increased by 44% year-over-year, driven by Global Platforms and Strategic Partnerships.
Group Solvency Ratio Decreased to 190%, a reflection of the redemption of a subordinated bond and the announcement of a new EUR200 million share buyback program.
New Business Strain Increased to $385 million, driven by growth in strategic assets, particularly in individual life and the General Account Stable Value product.
Operating Result from US EUR594 million, a decrease compared to the same period of 2023, with a 75% decrease in the operating result of the Financial Assets business segment.
Operating Result from Protection Solutions (US) Increased by 37%, benefiting from a growing profitable portfolio.
Operating Result from Savings & Investments (US) Increased by 14%, mainly from higher revenues in retirement plans.
Operating Result from Distribution Segment (US) Increased by 20%, mainly due to higher net commission revenues.
Annualized Net Outflows (Variable Annuity) 9% of the account balance, in line with expectations.
Annualized Net Outflows (Fixed Annuities) 11% of the average account balance, also in line with expectations.
Claims Experience Ratio (Long-term Care) Mildly unfavorable at 103% in the first half of 2024.
Cash Capital at Holding (End of June 2024) EUR2.1 billion, a decrease driven by the completion of the share buyback program.
Gross Financial Leverage Stable at EUR5.1 billion, following the redemption of a EUR700 million subordinated bond.
Operating Capital Generation Guidance for 2024 On track to meet guidance of around EUR1.1 billion.
Interim Dividend for 2024 EUR0.16 per share, an increase of EUR0.02 compared to the previous year.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Life Sales Growth: New life sales increased by 5% over the first half of last year, supported by all channels, particularly Indexed Universal Life policies.
Indexed Universal Life Policies: Sales of Indexed Universal Life policies drove growth, with attractive internal rates of return in excess of 12%.
Ancillary Products Growth: In the Savings & Investments segment, growth in ancillary products such as individual retirement accounts and stable value products was recorded, managing over $11 billion in assets.
US Distribution Reach: In the US, Aegon is expanding its distribution reach, with a 13% increase in licensed agents, totaling 79,000.
UK Workplace Platform Deposits: Net deposits in the UK Workplace platform amounted to GBP1.7 billion in the first half of 2024, driven by new and existing schemes.
International Segment Sales: New life sales in the International segment decreased by 20%, with Brazil showing a 9% increase, offset by weaker sales in China and Spain.
Capital Reduction: Aegon delivered approximately EUR400 million decrease in required capital over the first six months of 2024.
Share Buyback Program: Completed a EUR1.5 billion share buyback program and initiated a new EUR200 million buyback program expected to be completed by the end of 2024.
Cash Capital: Cash capital at the holding decreased to EUR2.1 billion, mainly due to returning capital to stockholders.
Strategic Asset Growth: Aegon aims to grow strategic assets while reducing exposure to financial assets, with a target of EUR1.1 billion operating capital generation for 2024.
Management Changes: Shawn Johnson appointed as CEO of Aegon Asset Management effective September 23, 2024, following key milestones.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Unfavorable Mortality Claims Experience: The IFRS operating result was negatively impacted by adverse mortality and morbidity claims experience, particularly in the US financial assets, leading to a decrease in operating results.
Regulatory Challenges in China and Spain: New pricing regulations in China and higher interest rates in Spain have negatively affected new life sales, contributing to a 20% decrease in international segment sales.
Competitive Pressures in the UK: The Adviser platform in the UK faced net outflows of GBP1.8 billion due to competition and low consumer activity, impacting overall performance.
Economic Factors Affecting Sales: Higher interest rates in Spain have tempered mortgage sales, resulting in lower sales of new life insurance and household insurance products linked to mortgages.
New Business Strain: New business strain increased to $385 million, driven by growth in strategic assets, indicating challenges in managing new business profitability.
Volatility in Investment Results: The group experienced unfavorable fair value items in the Americas due to underperformance in private equity and alternative investments, impacting overall financial results.
Cash Capital Decrease: Cash capital at the holding decreased to EUR2.1 billion, primarily due to capital returns to stockholders, which may affect liquidity.
Assumption Updates Impacting Liabilities: Updated mortality assumptions led to an increase in best estimate liabilities, which could affect future claims experience and operating results.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Strategic Initiatives: Aegon aims to grow its strategic assets and positions in core markets while reducing exposure to financial assets. The goal is to build leading businesses in investments, protection, and retirement solutions.
Agent Growth: Aegon plans to increase the number of agents in its World Financial Group (WFG) to 110,000 by 2027, with a 13% increase in licensed agents reported.
Net Deposits: Net deposits in the Savings & Investments segment reached $1.2 billion in the first half of 2024, supported by a large pooled plan sale.
UK Workplace Platform: Aegon expects annual net deposits in the UK Workplace platform to reach around GBP 5 billion by 2028.
International Sales: New life sales in Brazil increased by 9%, while sales in China and Spain decreased due to regulatory and market conditions.
Asset Management: Aegon reported strong third-party net deposits of EUR 5.1 billion in its Global Platforms business.
Operating Capital Generation Guidance: Aegon is on track to meet its EUR 1.1 billion operating capital generation guidance for 2024.
Free Cash Flow Guidance: The free cash flow guidance for 2024 is more than EUR 700 million, with over half achieved in the first half of the year.
Dividend Target: Aegon aims to increase the dividend to EUR 0.40 per share by 2025.
Operating Result Run Rate: The expected operating result run rate for the group is now projected to be between EUR 800 million to EUR 900 million per half-year.
New Business Strain: New business strain is expected to remain above $700 million for the remainder of 2024.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Interim Dividend 2024: EUR0.16 per share, an increase of EUR0.02 from the previous year.
Future Dividend Target: Target to increase the dividend to EUR0.40 per share by 2025.
Share Buyback Program: Completed a EUR1.5 billion share buyback program related to the ASR transaction.
New Share Buyback Program: Currently executing a new EUR200 million buyback program expected to be completed by the end of 2024.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:To what extent may assumption changes in the US make it easier for you to do a third-party in-force management action in the future?
A:The short answer is, no. We have just simply made an assumption update that we reflect our best estimate experience. It would have no real impact on any kind of management action that we would see in the future.
Q:Can we expect you to look at more in-force deals in Universal Life?
A:Universal Life is considered a financial asset and this is one of the books that we really want to run down over time.
Q:What do we need to see for you to be comfortable to reduce the holding cash towards the midpoint of the target range?
A:We have cash capital at the holding of roughly EUR2.1 billion. We expect to be near the top end of our range by the end of the third quarter.
Q:Can you give us some more color on both the alternative investments portfolio performance and the negative valuation in real estate and land?
A:The main driver of the alternative assets performance is linked to oil and natural gas prices. We saw a revaluation of those real estate holdings on a market value basis that reflects lower energy prices.
Q:Is there anything concerning regarding impairments with bond rating downgrades and mortgages model changes?
A:This is just market value noise. It does not really impact our ability to generate capital in the businesses at all.
Q:Does the changes you've made impact the operating capital generation?
A:On an IFRS basis, there will be an uplift in our expected operating result going forward. In the statutory framework, it creates a small drag on the operating result going forward.
Q:Can you talk about the large lives miss in terms of mortality?
A:We had mortality experience variances and we are going to continue to see volatility in the result.
Q:Can you explain the walk from today's 750 to the new operating result guidance of 800 to 900?
A:Yes, the balance of it is from business growth.
Q:How much of the reduction in locked in capital has been delivered by your actions versus markets?
A:I must say, I don't really have a good split for you. So we'll have to get back to you on that one.
Q:Any update on US GAAP reporting?
A:Work has not begun on US GAAP. We still want to make sure that we are really rock solid on our IFRS 17 figures.
Q:Can you please talk about the driver of the really high actual to expected in long-term care?
A:The majority of it is due to just simply a claims backlog that was caught up in the first half.
Q:At what point do you think you'll decide to maybe increase remittances from the US?
A:That could obviously change in the future.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the split between market actions and management actions in the reduction of locked-in capital. They also did not provide a clear timeline for when they might decide to increase remittances from the US.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Aegon
Americas
CSM
Cormier Head
EUR share
Financial Assets
GBP
Investments
Protection Solutions
account balance
age mortality
answer
capital asset
care book
change
completion
decrease
dividend EUR
equity market
experience variance
fee income
future
gain
impact
impairment
interest rate
investment income
math
mortality assumption
mortality experience
mortgage
noise
period asset
policy
reporting period
slide
stake ASR
strain
term care
uplift
AEG Transcript
Aegon Ltd. (AEG) Q4 2025 Earnings Call Transcript
Positive2-19
The earnings call summary presents a balanced view. Financial performance and product development are strong, with positive mortality variances and high new business strain. Market strategy and shareholder return plans are optimistic, with investments in growth and a focus on IFRS. The Q&A reveals some uncertainties, such as unclear management responses and legal settlements, but overall sentiment remains positive due to strong operational metrics and optimistic guidance.
Aegon Ltd. (AEG) Q2 2025 Earnings Call Transcript
Positive8-21
The earnings call reflects a solid financial performance with increased free cash flow and interim dividends, despite some negative aspects like decreased valuation equity per share. The company announced a share buyback program, which is typically seen positively. The Q&A did not reveal significant concerns, and management's confidence in achieving targets further supports a positive outlook. The market cap is not available, but the overall sentiment leans towards a positive reaction, likely resulting in a stock price increase of 2% to 8%.
Aegon N.V. (NYSE:AEG) Q1 2025 Earnings Call Transcript
Unknown5-20
The financial performance shows some positive aspects, such as increased operating capital generation and a healthy cash capital position. However, significant concerns include net outflows in retirement plans, market volatility impacting financial stability, and regulatory transition risks. The Q&A session highlighted uncertainty in capital return policies and unclear responses on mortality trends and hedging costs. The planned share buyback is positive but overshadowed by broader financial and strategic concerns, leading to a negative sentiment.
Aegon Ltd. (AEG) Q3 2024 Trading Update Call Transcript
Neutral11-15
AEG Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
